{"title": "Genomic epidemiology of a densely sampled COVID19 outbreak in China", "doi": "10.1101/2020.03.09.20033365", "citation_id": "2020.03.09.20033365v2", "date": "2020-03-19", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.09.20033365", "abstract": "<p>Analysis of genetic sequence data from the pandemic SARS Coronavirus 2 can provide insights into epidemic origins, worldwide dispersal, and epidemiological history. With few exceptions, genomic epidemiological analysis has focused on geographically distributed data sets with few isolates in any given location. Here we report an analysis of 20 whole SARS-CoV 2 genomes from a single relatively small and geographically constrained outbreak in Weifang, People9s Republic of China. Using Bayesian model-based phylodynamic methods, we estimate the reproduction number for the outbreak to be 1.99(95% CI:1.48-3.14).  We further estimate the number of infections through time and compare these estimates to confirmed diagnoses by the Weifang Centers for Disease Control.  We find that these estimates are consistent with reported cases and there is unlikely to be a large undiagnosed burden of infection over the period we studied.</p>", "twitter_description": "Analysis of genetic sequence data from the pandemic SARS Coronavirus 2 can provide insights into epidemic origins, worldwide dispersal, and epidemiological history. With few exceptions, genomic epidemiological analysis has focused on geographically distributed data sets with few isolates in any given location. Here we report an analysis of 20 whole SARS-CoV 2 genomes from a single relatively small and geographically constrained outbreak in Weifang, People's Republic of China. Using Bayesian model-based phylodynamic methods, we estimate the reproduction number for the outbreak to be 1.99(95% CI:1.48-3.14). We further estimate the number of infections through time and compare these estimates to confirmed diagnoses by the Weifang Centers for Disease Control. We find that these estimates are consistent with reported cases and there is unlikely to be a large undiagnosed burden of infection over the period we studied.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThis work was supported by Centre funding from the UK Medical Research Council under a concordat with the UK Department for International Development. NIHR. J-IDEA. This work was also supported by a grant from the Special Project for Prevention and Control of Pneumonia of New Coronavirus Infection in Weifang Science and Technology Development Plan in 2020 (2020YQFK015) to Associate Senior Technologist Qing Nie. Role of the Funders: All funders of the study had no role in study design, data analysis, data interpretation, or writing of the report. \n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nSequences are deposited in GISAID.\n\n<https://github.com/emvolz/weifang-sarscov2>\n\n<https://www.gisaid.org/>", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20033365v2.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20033365v2", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.09.20033365v2.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/19/2020.03.09.20033365.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.09.20033365v2", "access_rights": "restricted", "authors": ["Erik Volz", "Han Fu", "Haowei Wang", "Xiauoyue Xi", "Wei Chen", "Dehui Liu", "Yingying Chen", "Mengmeng Tian", "Wei Tan", "Junjie Zai", "Wanying Zan", "Xinguang Li", "Qing Nie"]}